Recently retired after 22 years of service at Eli Lilly & Company (most recently as Vice President for Global Regulatory Affairs), Tim was one of the original architects of PDUFA. He was also one of the first people the FDA recruited to discuss the nascent concept of the Critical Path. He loved the idea but also helped to identify some of the problems.
Tim is a guy who, as the old Jewish joke goes, "knows where the rocks are."
His regulatory knowledge is nonpareil and his optimism is contagious.
Among his many achievements, Tim has served on Drake University's Task Force on the College of Pharmacy and Health Sciences and is currently a member of the College of Pharmacy Dean's Advisory Board for Auburn University. Dr. Franson has authored over 50 articles and one text in the fields of infectious disease, epidemiology, pharmacoeconomics, and antibiotic utilization. He is board certified in Internal Medicine and Infectious Diseases.
We welcome his compassion, intelligence and commitment to the public health.
Center for Medicine in the Public Interest is a nonprofit, non-partisan organization promoting innovative solutions that advance medical progress, reduce health disparities, extend life and make health care more affordable, preventive and patient-centered. CMPI also provides the public, policymakers and the media a reliable source of independent scientific analysis on issues ranging from personalized medicine, food and drug safety, health care reform and comparative effectiveness.